# BioChem Sioux City Inc. - Inspection Records

Source: https://www.keypedia.com/companies/biochem-sioux-city-inc/5ce2b95e-6c89-4fb9-bbb4-210bd8272365

> Inspection records and compliance data for BioChem Sioux City Inc. in Sioux City, Iowa. Access full analysis and detailed observations.

---

## Details

- Name: BioChem Sioux City Inc.
- FEI Number: 1910218
- City: Sioux City
- State: Iowa
- Country Name: United States
- Address Line 1: 5500 1/2 Bradley St
- Zip Code: 51111

## Related Documents

- [FDA Inspection 1308836 - BioChem Sioux City Inc. - 2026-03-19](https://www.keypedia.com/records/fda_inspections/biochem-sioux-city-inc/43ec77e2-6e3d-4c3e-a452-db43a1b5c284) — source: FDA, date: March 19, 2026
- [483 - BioChem Sioux City Inc. - 2021-08-06](https://www.keypedia.com/records/483/biochem-sioux-city-inc/8cacec91-83aa-4431-af3e-1594777bb0cd) — source: FDA, date: August 6, 2021
- [FDA Inspection 1148612 - BioChem Sioux City Inc. - 2021-08-06](https://www.keypedia.com/records/fda_inspections/biochem-sioux-city-inc/c24d688d-90e3-4628-a18d-b87b9c5b7d2c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 6, 2021
- [FDA Inspection 1048693 - BioChem Sioux City Inc. - 2018-03-28](https://www.keypedia.com/records/fda_inspections/biochem-sioux-city-inc/9696bcd5-f39d-4379-896d-9282d4831fcd) — classification: No Action Indicated (NAI), source: FDA, date: March 28, 2018
- [FDA Inspection 751677 - BioChem Sioux City Inc. - 2011-11-02](https://www.keypedia.com/records/fda_inspections/biochem-sioux-city-inc/47b488eb-f476-4c71-8803-65b30278880b) — classification: No Action Indicated (NAI), source: FDA, date: November 2, 2011

## Related Companies

- [Cambridge Isotope Laboratories, Inc.](https://www.keypedia.com/companies/cambridge-isotope-laboratories-inc/bb7d8566-a216-469b-88ac-a3fa0060927e)
- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Piramal Pharma Limited](https://www.keypedia.com/companies/piramal-pharma-limited/c2aa1ac8-a474-4948-84c1-cd848c50558e)
- [Shouguang Fukang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shouguang-fukang-pharmaceutical-co-ltd/c6836369-cde1-4980-97c8-314af897d7e1)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [DDP Specialty Electronic Materials US 9, LLC](https://www.keypedia.com/companies/ddp-specialty-electronic-materials-us-9-llc/bfd7705b-0b03-4c4e-a3d7-d0940e04a868)
- [Vantage Specialty Ingredients Inc](https://www.keypedia.com/companies/vantage-specialty-ingredients-inc/e4309902-27de-4359-a655-fb59e6709e64)
- [Dishman Carbogen Amcis Limited](https://www.keypedia.com/companies/dishman-carbogen-amcis-limited/939c244d-55e9-4adb-8df2-1add2fe18427)
- [Cohance Lifesciences Limited](https://www.keypedia.com/companies/cohance-lifesciences-limited/8e48a668-3018-4c94-b846-2cdd61205a18)
- [ISP Sutton Laboratories](https://www.keypedia.com/companies/isp-sutton-laboratories/27126d09-6823-4e2b-8f31-d8645861af12)

## Related Officers

- [Matthew M. Schuckmann](https://www.keypedia.com/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)
- [ Investigator ](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)